Effects of atrasentan on markers of liver function in patients with type 2 diabetes and chronic kidney disease.

Autor: Kohan DE; Division of Nephrology, University of Utah Health, Salt Lake City, Utah, USA., Liew A; Mount Elizabeth Novena Hospital, Singapore., Tang SCW; Division of Nephrology, Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong, China., Barratt J; Department of Cardiovascular Sciences, University of Leicester, Leicester, UK., Heerspink HJL; Department of Clinical Pharmacy and Pharmacology, University of Groningen, Groningen, The Netherlands.
Jazyk: angličtina
Zdroj: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2023 Aug; Vol. 25 (8), pp. 2410-2412. Date of Electronic Publication: 2023 May 04.
DOI: 10.1111/dom.15103
Databáze: MEDLINE